Clarity Pharmaceuticals Ltd.ASX: CU6

SAR-bisPSMA Presentation - Drug & Device Conference

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX ·

Drug & Device ConferenceSAR-bisPSMA:A sensitive story12 October 2026For investor purposes onlyAll Clarity products mentioned in this presentation are investigational products and not approved by the US Food and Drug Administration (FDA).Dr Alan TaylorExecutive ChairpersonDisclaimerIntroductionThis...

View Attachment

6ix hasn’t read this filing yet.

Clarity Pharmaceuticals Ltd. on 6ix

In the deck

Story so far

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases